重大事件
即時報告
8-K
2026-06-16
Vaxcyte提交8
AI 繁中摘要
Vaxcyte（CIK: 0001649094）於2026年6月15日向SEC提交了一份8-K即時報告，主要事項為股東投票結果（Item 5.07）。該申報涵蓋2026年6月15日舉行的股東大會表決情況，但公開文件中未列出具體議案及票數細節。公司為特拉華州註冊的生物製品企業（SIC 2836），總部位於加州聖卡洛斯，財政年度年底為12月31日。投資者應留意後續補充披露或公司公告，以了解投票對公司治理、股權激勵計劃或重大交易的影響。是次8-K未涉及財務業績或營運更新。
展開英文正文
EDGAR Filing Documents for 0001649094-26-000021 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001649094-26-000021 Filing Date 2026-06-16 Accepted 2026-06-16 16:12:10 Documents 11 Period of Report 2026-06-15 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 8-K pcvx-20260615.htm iXBRL 8-K 46368 Complete submission text file 0001649094-26-000021.txt 165194 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20260615.xsd EX-101.SCH 1782 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20260615_lab.xml EX-101.LAB 22548 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20260615_pre.xml EX-101.PRE 13046 15 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20260615_htm.xml XML 3233 Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111 Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings) EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 261094757 SIC: 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)